[{"NetIncomeLoss_1_Q2_USD":9779987.0,"OperatingLeaseLiability_0_Q2_USD":197896.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"CommitmentsAndContingencies_0_Q2_USD":null,"AccruedLiabilitiesCurrent_0_Q2_USD":14405597.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-1191.0,"IncomeTaxesPaid_2_Q2_USD":49500.0,"TradingSecurities_0_Q2_USD":0.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":5000000.0,"Depreciation_2_Q2_USD":42953.0,"AccruedLiabilitiesCurrentAndNoncurrent_0_Q2_USD":14405597.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_2_Q2_USD":-10696.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":null,"AssetsCurrent_0_Q2_USD":131163687.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfOtherInvestments_2_Q2_USD":5000000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":20896406.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":10833358.0,"CostOfGoodsAndServicesSold_2_Q2_USD":8290739.0,"CostOfGoodsAndServicesSold_1_Q2_USD":4139873.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":4800000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":3500000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":36201.0,"AvailableForSaleSecurities_0_Q2_USD":84990900.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":28860.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":-84942.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":-10696.0,"FinanceLeaseLiability_0_Q2_USD":0.0,"Liabilities_0_Q2_USD":20210375.0,"ResearchAndDevelopmentExpense_2_Q2_USD":8572454.0,"ResearchAndDevelopmentExpense_1_Q2_USD":4349643.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":200343.0,"EarningsPerShareBasic_2_Q2_USD":0.2,"EarningsPerShareBasic_1_Q2_USD":0.09,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":106433862.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":106730423.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":447502.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":111269.0,"AccountsReceivableNetCurrent_0_Q2_USD":6762262.0,"IncomeTaxExpenseBenefit_2_Q2_USD":1223137.0,"CommonStockSharesIssued_0_Q2_shares":103422032.0,"IncomeTaxExpenseBenefit_1_Q2_USD":613172.0,"DepositsAssetsNoncurrent_0_Q2_USD":8888.0,"AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition_1_Q2_USD":167357.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":62350.0,"AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_1_Q2_USD":1627105.0,"OtherPrepaidExpenseCurrent_0_Q2_USD":292414.0,"IncreaseDecreaseInInventories_2_Q2_USD":-128868.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":20195306.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":9695045.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":1687331.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":115052248.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":null,"CommonStockValue_0_Q2_USD":103422.0,"Assets_0_Q2_USD":131411800.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q2_USD":-84942.0,"ShareBasedCompensation_1_Q2_USD":1794462.0,"EarningsPerShareDiluted_1_Q2_USD":0.09,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":21429139.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":10393159.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":20478188.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":103410881.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":103414523.0,"LiabilitiesCurrent_0_Q2_USD":20210375.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_2_Q2_USD":25540538.0,"AccountsPayableCurrent_0_Q2_USD":5804778.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":7521253.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":62350.0,"EarningsPerShareDiluted_2_Q2_USD":0.19,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":30502.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.0368,"WeightedAverageNumberDilutedSharesOutstandingAdjustment_2_Q2_shares":3022981.0,"WeightedAverageNumberDilutedSharesOutstandingAdjustment_1_Q2_shares":3315900.0,"AdditionalPaidInCapital_0_Q2_USD":219581816.0,"OperatingLeasePayments_2_Q2_USD":168122.0,"PrepaidInsurance_0_Q2_USD":622350.0,"AvailableForSaleSecuritiesGrossRealizedGainLossNet_1_Q2_USD":0.0,"AvailableForSaleSecuritiesGrossRealizedGainLossNet_2_Q2_USD":0.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":167514.0,"NetIncomeLoss_2_Q2_USD":20206002.0,"AccruedIncomeTaxesCurrent_0_Q2_USD":1081912.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":171483.0,"CommonStockSharesOutstanding_0_Q2_shares":103422032.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-108482622.0,"ShareBasedCompensation_2_Q2_USD":3313813.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":71711.0,"ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_0_Q2_shares":12322001.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.001,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.001,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":2447.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":3170179.0,"CommonStockSharesAuthorized_0_Q2_shares":150000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":58741236.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":29604764.0,"OperatingIncomeLoss_2_Q2_USD":20981637.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":-3774735.0,"OperatingIncomeLoss_1_Q2_USD":10281890.0,"PreferredStockValue_0_Q2_USD":0.0,"OperatingLeaseCost_2_Q2_USD":139513.0,"OperatingLeaseCost_1_Q2_USD":65434.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":131411800.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":2212733.0,"PreferredStockSharesAuthorized_0_Q2_shares":5000000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":197896.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_2_Q2_USD":-5473075.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_2_Q2_USD":19255.0,"ProfitLoss_2_Q2_USD":20206002.0,"StockholdersEquity_0_Q2_USD":111201425.0,"InventoryNet_0_Q2_USD":1827924.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":2464197.0,"Ticker":"CPRX","CIK":"1369568","name":"CATALYST PHARMACEUTICALS, INC.","OfficialName":"Catalyst Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"872304311.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200810"}]